Research library

Every indexed study on every peptide in the database, with a machine summary and the numbers that matter pulled out. Filter on the left; the register updates as you go.

2255studies indexed1010with human data129registered trials1946carry a numeric findingLibrarian added 23 studies today

Showing 10 studiesSortNewest indexed ▾

grade

Beyond Minoxidil: Off-Label Therapies for Male Androgenetic Alopecia-A Systematic Review with Network Meta-Analyses.

ABS-201 · Medicina (Kaunas, Lithuania) · 2026 · Meta-analysis

Topical minoxidil 5% is considered the most effective off-label therapy for male androgenetic alopecia, but other treatments may also show potential benefits.

Not reported in abstract.

summary

Full text read

Source →

grade

The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors.

ABS-201 · British journal of pharmacology · 2023 · Review

The Concise Guide to PHARMACOLOGY 2023/24 is a comprehensive reference for drug targets and their interactions, useful for both researchers and clinicians.

Not reported in abstract.

summary

Full text read

Source →

grade

Insightful Backbone Modifications Preventing Proteolytic Degradation of Neurotensin Analogs Improve NT<i>S1</i>-Induced Protective Hypothermia.

ABS-201 · Frontiers in chemistry · 2020 · Animal study · Preclinical

Backbone modifications in NT(8-13) analogs improve stability and hypothermic efficacy, highlighting potential for neuroprotective applications.

Sustained hypothermic effect of -3°C for at least 1 hour.

summary

Full text read

Source →

grade

Pharmacological hypothermia induced neurovascular protection after severe stroke of transient middle cerebral artery occlusion in mice.

ABS-201 · Experimental neurology · 2020 · Animal study · Preclinical

HPI-201-induced hypothermia shows potential for neurovascular protection in mice after severe stroke, but human applicability is unclear.

Not reported in abstract.

summary

Full text read

Source →

grade

Targeted temperature management and early neuro-prognostication after cardiac arrest.

ABS-201 · Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2021 · Review

TTM for at least 24 hours with slow rewarming is recommended post-cardiac arrest, but further research is needed to optimize its implementation.

summary

Full text read

Source →

grade

Surface Functionalization of Nanocarriers with Anti-EGFR Ligands for Cancer Active Targeting.

ABS-201 · Nanomaterials (Basel, Switzerland) · 2025 · Review

Anti-EGFR nanocarriers hold promise for targeted cancer therapy, but further clinical validation is needed.

summary

Full text read

Source →

grade

A peptide-neurotensin conjugate that crosses the blood-brain barrier induces pharmacological hypothermia associated with anticonvulsant, neuroprotective, and anti-inflammatory properties following status epilepticus in mice.

ABS-201 · eLife · 2025 · Animal study · PreclinicalHigh-impact journal

VH-N412 shows potential for inducing neuroprotective hypothermia in a mouse model, but further research is needed to assess its clinical relevance.

Not reported in abstract.

summary

Full text read

Source →

grade

Artificial intelligence-enabled precision medicine for inflammatory skin diseases.

ABS-201 · The Journal of investigative dermatology · 2026 · Review

AI holds promise for advancing the diagnosis and treatment of inflammatory skin diseases, but its clinical integration requires careful validation.

summary

Full text read

Source →

grade

Emerging pharmacotherapies for androgenetic alopecia.

ABS-201 · Expert opinion on pharmacotherapy · 2026 · Review

Emerging therapies for androgenetic alopecia, including ABS-201, offer new mechanisms of action, but their clinical efficacy and safety need validation in future trials.

summary

Full text read

Source →

grade

Emerging pharmacotherapies for androgenetic alopecia.

ABS-201 · Expert opinion on pharmacotherapy · 2026 · Review

Confirms ABS-201 is in clinical development for androgenetic alopecia as a prolactin-receptor-targeting biologic. It contains no data on whether it works.

summary

Partial text

Source →

Showing 10 of 10